NCT03054428 · Interventional trial
Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
Overall registry status Completed
Phase 3
Conditions Dermatitis, Atopic, Dermatitis, Dermatitis Atopic, Disease, Eczematous Skin, Diseases Genetic, Genetic, Diseases Inborn, Skin, Eczema, Skin Diseases, Skin, Hypersensitivity, Immediate, Hypersensitivity, Immune System Diseases, Moderate-to-Severe Atopic Dermatitis
Delaware Valley sites
- Regeneron Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory